You are here

Europe

AstraZeneca looks to rebound from production delays for its Covid-19 vaccine with new fill-finish deal

AstraZeneca looks to rebound from production delays for its Covid-19 vaccine with new fill-finish deal

Endpoints

drug manufacturing

Flag link:

First look inside BioNTech's Marburg site as it starts production for COVID-19 vaccine

First look inside BioNTech's Marburg site as it starts production for COVID-19 vaccine

Biopharma Reporter

drug manufacturing

Flag link:

What does Brexit mean for biopharma companies?

What does Brexit mean for biopharma companies?

Biopharma Reporter

Flag link:

Novavax starts rolling reviews for COVID-19 vaccine

Novavax starts rolling reviews for COVID-19 vaccine

Biopharma Reporter

Flag link:

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA

Drug Patent Watch

Flag link:

Janssen flags accelerated approval milestone in Europe for CAR-T therapy

Janssen flags accelerated approval milestone in Europe for CAR-T therapy

Biopharma Reporter

Flag link:

AstraZeneca to supply nine million more vaccines to EU

AstraZeneca to supply nine million more vaccines to EU

Pharmaforum

Flag link:

AstraZeneca defends slow supplies to the EU, but says it ordered 3 months later than the UK

AstraZeneca defends slow supplies to the EU, but says it ordered 3 months later than the UK

CNBC

Flag link:

[video+transcript]How Are COVID Vaccine Rollouts Going in Europe?

[video+transcript]How Are COVID Vaccine Rollouts Going in Europe?

Motley Fool

Flag link:

Russia asks for “non-political” treatment of Sputnik V shot, then rules out US filing

Russia asks for “non-political” treatment of Sputnik V shot, then rules out US filing

Pharmaforum

Flag link:

Pfizer and BioNTech, scaling up for 2B coronavirus vaccine doses, temporarily cut deliveries in EU, Canada

Pfizer and BioNTech, scaling up for 2B coronavirus vaccine doses, temporarily cut deliveries in EU, Canada

Fierce Pharma

drug manufacturing

Flag link:

BioGeneration Ventures closes 4th fund, with $170M in tow for early European biotechs

BioGeneration Ventures closes 4th fund, with $170M in tow for early European biotechs

Fierce Biotech

BioGeneration Ventures

venture capital

Bristol Myers Squibb

Flag link:

Moderna Coronavirus Vaccine Approved in Europe

Moderna Coronavirus Vaccine Approved in Europe

Motley Fool

Moderna Therapeutics

Flag link:

Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union

Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union

Motley Fool

Flag link:

EU is asked to approve extra dose from Pfizer vaccine vials

EU is asked to approve extra dose from Pfizer vaccine vials

Yahoo/Reuters

Flag link:

Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe

Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe

Motley Fool

Flag link:

European Union to start COVID-19 vaccinations on December 27

European Union to start COVID-19 vaccinations on December 27

Biopharma Reporter

Flag link:

Novartis’ $9.7B PCSK9 drug nabs first OK — now comes the challenge of finding a market

Novartis’ $9.7B PCSK9 drug nabs first OK — now comes the challenge of finding a market

Endpoints

Flag link:

Forbion raises €460M in weeks to back next crop of EU biotechs

Forbion raises €460M in weeks to back next crop of EU biotechs

Fierce Biotech

venture capital

Flag link:

AstraZeneca offloads former crown jewel Crestor as it continues to refocus on oncology drugs

AstraZeneca offloads former crown jewel Crestor as it continues to refocus on oncology drugs

Endpoints

Flag link:

Pages